Intraoperative identification of sentinel lymph node in patients with malignant melanoma

British Journal of Cancer

Volumn 75, Issue 10, 1997, Pages 1505-1508

  Lingam, M K ^a,c   Mackie, R M ^b   McKay, A J ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Lymphatic mapping; Malignant melanoma; Sentinel node

Indexed keywords

DISULFINE BLUE; EOSIN; HEMATOXYLIN;

ARTICLE; AXILLA; HUMAN; HUMAN TISSUE; INGUINAL REGION; LYMPH; LYMPH NODE; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MELANOMA; METASTASIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

EID: 0031004246     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.257     Document Type: Article

References (15)

1. Balch CM (1980) Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol 3: 511-524
2. Balch CM (1988) The role of elective lymph node dissection in melanoma: Rationale, results and controversies. J Clin Oncol 6: 163-172
3. Balch C, Wilkerson J, Murad T, Soong SJ, Ingalls AL and Maddox WA (1980) The prognostic significance of ulceration of cutaneous melanoma. Cancer 45: 3012-3017
4. Cochran AJ, Wen DR, Herschman HR and Gayner RB (1982) Detection of S-100 protein as an aid to the identification of melanocytic tumours. Int J Cancer 30: 295-247
5. Cochran AJ, Wen DR and Morion DL (1988) Occult tumour cells in the lymph nodes of patients with pathological stage 1 malignant melanoma. An immunohistological study. Am J Surg Pathol 12: 612-618
6. Cochran AJ, Wen DR and Morton DL (1992) Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J Surg 16: 214-221
7. Day CL Jr, Mihm MC Jr, Lew RA, Harris MN, Kopf AW, Fitzpatrick TB, Harrist TJ, Golomb FM, Postel A, Hennessey P, Gumport SL, Rator JW, Malt RA, Cosimi AB, Wood WC, Roses DF, Gorstein F, Rigel D, Friedman RJ, Mintzis MM and Sobei AJ (1982) Prognostic models for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). A conceptual model for tumour growth and metastases. Ann Surd 195: 35-43
8. Das Gupta TK (1977) Results of treatment of 269 patients with primary cutaneous melanoma: A five year prospective study. Ann Surg 7 186: 201-209
9. Koehler PR (1966) Complication and accidents. In Progress in Lymphology. Proceeding of the International Symposium on Lymphology, 1996, Zurich, Ruttiman A (ed.), pp. 306-308. Georg Thieme: Stuttgart
10. Morton DL, Wanek L, Nizze JA, Elashoff ITM and Wong JH (1991) Improved long term survival alter lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 214: 491-499
11. Morton DL, Wen DR, Wang JH, Economou JS, Cagle LA, Storm FK, Fo Shag LJ and Cochran AJ (1992) Technical details of intraoperative lymphatic mapping tor early stage melanoma. Arch Surg 127: 392-399
12. Reinigen D, Cruse WC, Wells K, Berman C, Tenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rappaport D, Seigler HF and Balch C (1994) The orderly progression of melanoma nodal metastases. Ann Surg 6: 759-767
13. Roses DF, Provet JA, Harris MN, Gumport SL and Dublin N (1985) Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann Surg 201: 103-107
14. Scott RN and McKay AJ (1993) Elective lymph node dissection in the management of malignant melanoma. Br J Surg 80: 284-288
15. van der Veen H, Hoekstra OS, Paul MA, Cuesta MA and Meijer S (1994) Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 81: 1769-1770